No Cover Image

Journal article 174 views 30 downloads

Risk of severe COVID-19 outcomes after autumn 2022 COVID-19 booster vaccinations: a pooled analysis of national prospective cohort studies involving 7.4 million adults in England, Northern Ireland, Scotland and Wales

Stuart Bedston, Fatima Almaghrabi Orcid Logo, Lynsey Patterson, Utkarsh Agrawal Orcid Logo, Lana Woolford, Sneha N. Anand, Mark Joy, Anna Crawford Orcid Logo, Rosalind Goudie, Rachel Byford, Hoda Abbasizanjani Orcid Logo, Deb Smith, Lynn Laidlaw, Ashley Akbari Orcid Logo, Christopher Sullivan, Declan T. Bradley, Ronan Lyons Orcid Logo, Simon de Lusignan, F.D. Richard Hobbs, Chris Robertson, Sir Aziz Sheikh, Ting Shi Orcid Logo

The Lancet Regional Health - Europe, Volume: 37, Start page: 100816

Swansea University Authors: Stuart Bedston, Hoda Abbasizanjani Orcid Logo, Ashley Akbari Orcid Logo, Ronan Lyons Orcid Logo

  • 65336.pdf

    PDF | Version of Record

    This is an open access article distributed under the terms of the Creative Commons CC-BY license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

    Download (600.52KB)
Published in: The Lancet Regional Health - Europe
ISSN: 2666-7762
Published: Elsevier BV 2024
Online Access: Check full text

Tags: Add Tag
No Tags, Be the first to tag this record!
Keywords: COVID-19; Vaccine; Hospital admission; Vaccine breakthrough; Booster dose
College: Faculty of Medicine, Health and Life Sciences
Funders: National Core Studies—Immunity, UK Research and Innovation (Medical Research Council and Economic and Social Research Council), Health Data Research UK, the Scottish Government, and the University of Edinburgh.
Start Page: 100816